CDC: Vaccination safe for pregnant women; Veterans Affairs leaves Aduhelm off its formulary; gerontologist Aubrey de Grey placed on leave following harassment allegations.
Five things for health marketers to know: Wednesday, August 11, 2021
Scientists examine potential of intranasal COVID-19 vaccines; Harmony Biosciences secures $330 million in deal with Blackstone; NIH to study effect of booster shots on kidney transplant patients.
Five things for health marketers to know: Tuesday, August 10, 2021
Fauci calls for more COVID-19 testing among vaccinated; Gilead mandates vaccination for employees; Bluebird Bio stops gene therapy trial due to safety risks.
Five things for health marketers to know: Monday, August 9, 2021
United Airlines becomes first large airline to mandate vaccination; Ji Xing acquires Oyster Point’s nasal spray for dry eye; Health workers across U.S. experience pandemic burnout.
Five things for health marketers to know: Friday, August 6, 2021
U.S. COVID-19 cases reach highest level in six months; biotech entrepreneur Tadataka Yamada dies at 76; Athira Pharma cites altered papers in NIH grant application.
Five things for health marketers to know: Thursday, August 5, 2021
WHO asks wealthy nations to delay booster shots; CVS Health reports increase in revenue due to vaccinations; Biogen and Eisai push for lecanemab approval.
Five things for health marketers to know: Wednesday, August 4, 2021
CDC says fully vaccinated people can spread Delta variant; Moderna deals with Autolus for mRNA-based immuno-oncology candidates; Vaccine booster shots could be needed by September.
Five things for health marketers to know: Monday, August 2, 2021
Internal CDC document calls Delta variant as contagious as chickenpox; AbbVie to develop Alzheimer’s treatment; Asian countries impose strict COVID-19 restrictions.
Five things for health marketers to know: Friday, July 30, 2021
Biden administration to ask federal workers for proof of vaccination; CDC: 70% of U.S. counties should return to masking; Eli Lilly set to acquire Kumquat’s immuno-oncology franchise.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix